New Brain-Targeting drug tested for stubborn seizures
NCT ID NCT07095933
Summary
This small, early-stage study is testing whether adding the drug everolimus to a person's current anti-seizure medications can help reduce seizure frequency in adults with focal epilepsy that doesn't respond well to standard drugs. The idea is based on research suggesting everolimus might interfere with how the brain 'remembers' seizure patterns. Researchers will measure changes in seizure frequency and severity over a 12-week period to see if this approach is safe and helpful.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Xuanwu Hospital, Beijing
RECRUITINGBeijing, Beijing Municipality, 100053, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.